Ali S. Arbab
- Genetics top 0.2%
- Glioma Diagnosis and Treatment 30
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery 19
- Developmental Neuroscience top 1%
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 30
- Immunology top 2%
- Immune cells in cancer 23
-
- Angiogenesis and VEGF in Cancer 25
- RNA Interference and Gene Delivery 15
-
- Advanced MRI Techniques and Applications 21
- MRI in cancer diagnosis 14
- Co-authors
- Joseph A. FrankElaine JordanBobbi K. LewisGene T. YocumHeather KalishJeff W. M. BulteStasia A. AndersonAsm Iskander
- Partner nations
- United StatesJapanBrazil
In The Last Decade
Ali S. Arbab
206 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Genetics 2.0k
- Biomaterials 2.0k
- Developmental Neuroscience 468
- Cancer Research 1.3k
- Immunology 1.5k
Countries citing papers authored by Ali S. Arbab
This map shows the geographic impact of Ali S. Arbab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali S. Arbab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali S. Arbab more than expected).
Fields of papers citing papers by Ali S. Arbab
This network shows the impact of papers produced by Ali S. Arbab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali S. Arbab. The network helps show where Ali S. Arbab may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali S. Arbab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 141 | |
| 6 | 2020 | 6 | |
| 7 | 2018 | 21 | |
| 8 | 2017 | 60 | |
| 9 | 2017 | 287 | |
| 10 | 2016 | 251 | |
| 11 | Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling. | 2014 | 23 |
| 12 | The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: A regulator of endothelial precursor cells derived from human umbilical cord blood (Journal of Pharmacology and Experimental Therapeutics (2011) 338, (421-429)) | 2012 | 6 |
| 13 | 2011 | 67 | |
| 14 | 2008 | 6 | |
| 15 | 2008 | 149 | |
| 16 | 2007 | 100 | |
| 17 | 2005 | 122 | |
| 18 | Clinically Applicable Labeling of Mammalian and Stem Cells by Combining Superparamagnetic Iron Oxides and Transfection Agentsbreakdown → | 2003 | 544 |
| 19 | 1997 | 31 | |
| 20 | 1996 | 6 |
About Ali S. Arbab
Ali S. Arbab is a scholar working on Genetics, Cancer Research and Toxicology, having authored 209 papers that have together received 10.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (30 papers), Cancer, Hypoxia, and Metabolism (30 papers), Angiogenesis and VEGF in Cancer (25 papers), Immune cells in cancer (23 papers), Advanced MRI Techniques and Applications (21 papers), Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (15 papers) and MRI in cancer diagnosis (14 papers). The work is most often cited by research in Genetics (2.0k citations), Biomaterials (2.0k citations) and Developmental Neuroscience (468 citations). Ali S. Arbab has collaborated with scholars based in United States, Japan and Brazil. Frequent co-authors include Joseph A. Frank, Elaine Jordan, Bobbi K. Lewis, Gene T. Yocum, Heather Kalish, Jeff W. M. Bulte, Stasia A. Anderson, Asm Iskander, Thaiz F. Borin and Branislava Janic. Their work appears in journals such as Cancer Research, PLoS ONE, Annals of Nuclear Medicine, Nuclear Medicine Communications and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.